Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.
Cancer Immunol Immunother
; 68(2): 233-245, 2019 Feb.
Article
in En
| MEDLINE
| ID: mdl-30382327
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CD40 Antigens
/
Immunotherapy
/
Antibodies, Monoclonal
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2019
Document type:
Article
Affiliation country:
Estados Unidos